Kindos Company Profile
✉ Email this page to a colleague
What is the competitive landscape for KINDOS, and what generic and branded alternatives to KINDOS drugs are available?
KINDOS has two approved drugs.
Drugs and US Patents for Kindos
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Kindos | ROPIVACAINE HYDROCHLORIDE | ropivacaine hydrochloride | SOLUTION;INJECTION | 218713-005 | Jul 30, 2024 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Kindos | ROPIVACAINE HYDROCHLORIDE | ropivacaine hydrochloride | SOLUTION;INJECTION | 218713-007 | Jul 30, 2024 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Kindos | ROPIVACAINE HYDROCHLORIDE | ropivacaine hydrochloride | SOLUTION;INJECTION | 218713-001 | Jul 30, 2024 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |